0001942129-26-000001.txt : 20260820
0001942129-26-000001.hdr.sgml : 20260820
20260820151955
ACCESSION NUMBER: 0001942129-26-000001
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(1)
FILED AS OF DATE: 20260820
DATE AS OF CHANGE: 20260820
EFFECTIVENESS DATE: 20260820
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Omnimed Equity Partners II LP
CENTRAL INDEX KEY: 0001942129
ORGANIZATION NAME:
EIN: 880829950
STATE OF INCORPORATION: TX
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-456954
FILM NUMBER: 261299444
BUSINESS ADDRESS:
STREET 1: 8383 PRESTON CENTER PLAZA DR.
STREET 2: SUITE 360
CITY: DALLAS
STATE: TX
ZIP: 75225
BUSINESS PHONE: 972-701-5412
MAIL ADDRESS:
STREET 1: 8383 PRESTON CENTER PLAZA DR.
STREET 2: SUITE 360
CITY: DALLAS
STATE: TX
ZIP: 75225
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001942129
Omnimed Equity Partners II LP
8383 PRESTON CENTER PLAZA DR.
SUITE 360
DALLAS
TX
TEXAS
75225
972-701-5412
TEXAS
None
None
Limited Partnership
true
2022
Gregory
N/A
Wood
8383 PRESTON CENTER PLAZA DR.
SUITE 360
DALLAS
TX
TEXAS
75225
Director
Managing Director of the General Partner of the Issuer.
Gary
N/A
Wood
8383 PRESTON CENTER PLAZA DR.
SUITE 360
DALLAS
TX
TEXAS
75225
Director
Managing Director of the General Partner of the Issuer.
N/A
N/A
Omnimed Capital, LLC
8383 PRESTON CENTER PLAZA DR.
SUITE 360
DALLAS
TX
TEXAS
75225
Director
Promoter
General Partner of the Issuer.
Pooled Investment Fund
Private Equity Fund
false
Decline to Disclose
- 06b
- 3C
- 3C.1
true
0001942129-25-000002
2022-08-09
false
true
true
true
false
100000
Indefinite
10600000
Indefinite
false
60
0
0
0
true
The Issuer's affiliate will receive reimbursements, management fees, and performance allocations as described in the Issuer's offering documents.
false
Omnimed Equity Partners II LP
/s/ Gregory Wood
Gregory Wood
Managing Director of the General Partner of the Issuer
2026-08-20